Sign In
Buy EVLO
$0.0001
+0 (+0%)
At Close: Jun 22, 2026
Evelo Biosciences to Present at Virtual BMO 2020 Prescriptions for Success Healthcare Conference
11:00am, Tuesday, 16'th Jun 2020
Evelo Biosciences, Inc. (EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today announced that management will participate in
COVID-19 Impact and Recovery Analysis- Microbiomes Market 2020-2024 | Increasing Prevalence Of Diseases to Boost Growth | Technavio
12:00am, Tuesday, 16'th Jun 2020
The Global Microbiomes Market will grow by $ 544.72 mn during 2020-2024
Global Nivolumab Market 2020 Industry Analysis by Key Players, Product Type, Application, Regions and Forecast to 2026
11:55am, Sunday, 07'th Jun 2020
Jun 07, 2020 (CDN Newswire via Comtex) --
The dedicated research report titled Global Nivolumab Market 2020 by Manufacturers, Regions, Type and Application,...
Evelo Biosciences, Inc. (EVLO) Upgraded to Strong Buy: What Does It Mean for the Stock?
04:00pm, Friday, 29'th May 2020
Evelo Biosciences, Inc. (EVLO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).
Flagship Pioneering, a unique life sciences innovation enterprise, today announced that it has further strengthened its executive leadership team with the appointment of Fabrice Chouraqui to the newly
Evelo Biosciences to Present at Jefferies Virtual Healthcare Conference
11:00am, Thursday, 28'th May 2020
Evelo Biosciences, Inc. (EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today announced that management will participate in
Evelo Biosciences, Inc. (EVLO): Hedge Fund Sentiment Unchanged
04:34pm, Wednesday, 27'th May 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Evelo Biosciences Sees Hammer Chart Pattern: Time to Buy?
03:30pm, Wednesday, 27'th May 2020
Evelo Biosciences has been struggling lately, but the selling pressure may be coming to an end soon.
Before You Buy Evelo Biosciences, Inc. (NASDAQ:EVLO), Consider Its Volatility
06:58pm, Thursday, 14'th May 2020
If you own shares in Evelo Biosciences, Inc. (NASDAQ:EVLO) then it's worth thinking about how it contributes to the...
Evelo Biosciences Inc (EVLO) CEO Simba Gill on Q1 2020 Results - Earnings Call Transcript
04:21am, Wednesday, 13'th May 2020
Evelo Biosciences Inc (NASDAQ:EVLO) Q1 2020 Results Conference Call May 11, 2020 8:30 AM ET Company Participants Jessica Cotrone - VP & Head of Communicatio
U.S. RESEARCH ROUNDUP-Digital Realty Trust, Pilgrims Pride, Terraform Power
07:26am, Tuesday, 12'th May 2020
Wall Street securities analysts revised their ratings and price targets on
several U.S.-listed companies, including Digital Realty Trust, Pilgrims Pride and Terraform Power,
on Tuesday.
HIGH
Evelo Biosciences Reports First Quarter Financial Results and Business Highlights
11:00am, Monday, 11'th May 2020
–Submitted investigational new drug (IND) application for a Phase 2 trial of EDP1815 for COVID-19; data readout expected during 2H 2020––Selected enteric capsule formulation of.
Ulcerative Colitis Industry Review and Outlook 2016-2024 - ResearchAndMarkets.com
12:00am, Monday, 11'th May 2020
The
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
Evelo Biosciences, Inc. (EVLO), Rutgers University, and Robert Wood Johnson University Hospital today announced the submission of an Investigational New Drug (IND) application for an Evelo-sponsored P
